Background : Human artificial chromosomes (HACs) are generated from the precursor DNA constructs containing α α α α -satellite DNA with CENP-B boxes, and the process could be used for the incorporation of large genes in the HACs. Guanosine triphosphate cyclohydrolase I (GCH1) is the first and rate-limiting enzyme for the biosynthesis of tetrahydrobiopterin, the essential co-factor of aromatic amino acid hydroxylases and nitric oxide synthase.
Introduction
Mitotically stable human artificial chromosomes (HACs), several mega-base pairs in size, are frequently generated de novo in the human fibroblast cell line, HT1080, upon introduction of precursor DNA constructs in either linear (YAC) or circular form (BAC or PAC (p1-derived artificial chromosome)) containing several tens of kilobases of human α -satellite (alphoid) DNA with frequent CENP-B boxes Masumoto et al . 1998; Henning et al . 1999; Ebersole et al . 2000) . Since essential kinetochore proteins are detected on such HACs, the input α -satellite arrays are capable of assembling a de novo active centromere/kinetochore structure similar to that of authentic human chromosomes (Ikeno et al . 1994 Masumoto et al . 1998; Henning et al . 1999; Ebersole et al . 2000; Ando et al . 2002) . Since HACs duplicate once every cell cycle utilizing cellular protein factors, they also contain replication origin(s) in the alphoid sequence. Linear HACs made from the alphoid-YAC with telomere sequences acquired a functional telomere structure at the ends of the HACs, but circular HACs made from BAC or PAC had no telomere structure Ebersole et al . 2000) .
Treating human diseases by gene therapy is a challenging and promising field. Although we now have at hand tens of thousands of genes by which we might be able to cure defective human genes or to characterize in detail their function and regulation, the major obstacle still lies in the development of effective gene delivery technology. Presently available vectors for mammalian cells are mainly derived from small viruses (Mineta et al . 1995; Fisher et al . 1997; Pfeifer & Verma 2001) . Although they have the advantage of highly efficient transduction of the genes of interest (transgenes), their cloning capacity is limited. They are too small to include large genome segments with tissue-specific regulatory regions. Moreover, transgenes are usually stably maintained only after random integration into host-cell chromosomes, gene expression from which is usually unpredictable (mostly suppressed) and not under the control of the authentic regulatory region of the genes. Even worse, this step has the potential to induce unfavourable mutagenesis.
In contrast, HACs have the capacity to accommodate a large transgene with a controlling region in excess of 100 kb of DNA. HACs containing transgenes are generated de novo from a precursor construct with both the transgene and an alphoid array (Mejia et al . 2001) , or from precursor constructs containing an alphoid array and the transgene in separate entities (Grimes et al . 2001 ). Thus, HACs may be used not only as vectors in therapeutic applications but also as model systems useful in analyses of tissue or organ specific regulation of gene expression that would only be possible with large genome segments.
Considering not only basic studies into gene regulation but also future therapeutic applications, we constructed HACs containing 180 kb genome segments encoding human guanosine triphosphate (GTP) cyclohydrolase I (EC 3.5.4.16; GCH1) . One human GCH1 gene is located in chromosome 14q22.1-q22.2, and the gene is composed of six exons spanning more than 60 kb ( Fig. 1) (Ichinose et al . 1995; Hubbard et al . 2002) . GCH1 is the first enzyme for the biosynthetic pathway of tetrahydrobiopterin, the essential co-factor for enzymatic reactions as described below and is present in higher organisms (Nichol et al . 1985; Tanaka et al . 1989; Werner et al . 1990) . Tetrahydrobiopterin is synthesized from GTP in a three-step reaction by GCH1, 6-pyruvoyltetrahydropterin synthase (EC 4.6.1.10; PTPS) and sepiapterin reductase (EC 1.1.1.153; SR). Among these enzymes, the major controlling point is GCH1, the expression of which is under the control of cytokine induction (Werner et al . 1993 ) and the feedback regulatory protein, GFRP, at the transcriptional and post-translational levels, respectively. Tetrahydrobiopterin functions as a Figure 1 Constructs of alphoid-BACs and GCH1-BAC. CMV/α100 BAC contains 100 kb of the α21-I alphoid array from human chromosome 21 and a CMVBsd (Blasticidin S deaminase gene from Aspergillus terreus) selection marker for mammalian cells in the BAC vector. SV/α50 BAC contains 50 kb of the α21-I alphoid array and an SV2-Bsr (Blasticidin S deaminase gene from Bacillus cereus) selection marker. GCH1-BAC contains a 180 kb genomic DNA fragment containing the GCH1 gene. The regions used as probes for the FISH analysis, Southern analysis and exons (1-6) of the GCH1 gene are indicated as shadowed boxes, black boxes and open boxes, respectively. BAC vectors contain chloramphenicol-resistance gene (Cm) for selection in E. coli. natural co-factor of the aromatic amino acid hydroxylases, phenylalanine hydroxylase (EC 1.14.16.2; PAH), tyrosine hydroxylase (EC 1.14.16.3; TH), the first and rate-limiting enzyme of dopamine synthesis, tryptophan 5-hydroxylase (EC 1.14.16.4; TPH), serotonin biosynthesis. Tetrahydrobiopterin is also essential for all three forms of nitric oxide synthase (NOS) (Kaufman 1993) . Decreases in GCH1 activity, tetrahydrobiopterin level and/or TH activity causes a dopamine deficiency in the nigrostriatum dopamine neurones and provokes several well-known clinical symptoms, such as hereditary doparesponsive dystonia (DRD/Segawa's syndrome) (Ichinose et al . 1994) or parkinsonism. Thus, HACs carrying the GCH1 gene with the authentic regulatory region would almost certainly prove useful for compensating for the defects in the GCH1 gene as well as facilitating a close study of the complex regulatory mechanism of GCH1 gene expression in vivo .
In this study, we co-transfected the GCH1-BAC containing a 180 kb genomic region covering the entire GCH1 gene and its upstream control region and the alphoid-BAC containing a 50 kb or 100 kb alphoid array to the HT1080 cells, and generated HACs containing multiple copies of GCH1 genes. We were able to show that the HACs are stably maintained both in human and mouse cells without selection. GCH1 activity arising from human fibroblast cells with a GCH1-HAC is elevated, but when interferon-γ (IFN-γ ) is added to the culture medium, GCH1 activity is further upregulated, as is observed with the gene expression from the host cell chromosomes. These results show that the GCH1-HAC will not only provide a good system for study of the complex regulatory mechanism of the GCH1 gene in cells and bodies but will also be useful as a gene delivery tool for animal models or in therapeutic trials. The HAC vector system will open the simple and general way to the delivery of very large genes with an original regulatory region.
Results
Generation of HAC containing the GCH1 genomic locus α 21-I alphoid, consisting of an 11mer higher order repeat unit derived from human chromosome 21 (Ikeno et al . 1994) , is able to generate a HAC efficiently when it is introduced into HT1080 cells ). We generated HACs containing a GCH1 genomic locus with naturally regulated gene expression, utilizing alphoid-BACs and GCH1-BAC. The BACs used in this study are shown in Fig. 1 . CMV/ α 100 contains 100 kb of an α 21-I alphoid array and a CMV-Bsd as a selectable marker, and SV/ α 50 contains 50 kb of an α 21-I alphoid array and a SV2-Bsr selection marker. The GCH1-BAC was obtained from a BAC library (Genome systems) and has a 180 kb genomic DNA fragment containing the GCH1 gene. We co-transfected either one of the alphoid-BACs and the GCH1-BAC in a 1: 1 molecular ratio into HT1080 cells by lipofection and isolated Blasticidin S (BS) resistant cell lines after 10 days. To detect the presence of HAC as an extrachromosomal element, the BS-resistant cell lines were analysed by FISH using both α 21-I alphoid DNA and BAC vector as probes. One out of 16 transformed cell lines obtained by the cotransfection of CMV/ α 100 and GCH1-BAC, and three out of 17 cell lines obtained by the co-transfection of SV/ α 50 and GCH1-BAC, contained one copy of HAC per nuclei in more than 95% of the inspected cells (Table 1 ). In the remaining cell lines, introduced BACs CMV/α100 BAC 16 1 4 11 1 (HT/GCH2-10) +GCH1-BAC SV/α50 BAC 17 3 13 1 1 (HT/GCH5-18) +GCH1-BAC BS-resistant cell lines obtained by co-transfection of GCH1-BAC plus CMV/α100 BAC or SV/α50 BAC were analysed by FISH. 'HAC' indicates cell lines with an artificial chromosome detected both with α21-I alphoid DNA and BAC vector probes. One copy of HAC was detected in more than 95% of the inspected metaphase spread of these cell lines. In the remaining cell lines, introduced BACs were either integrated into the chromosomes of HT1080 (Chromosome) or the signals were undetectable (Non) by FISH analysis. 'HAC with GCH1' indicates the cell lines carrying a HAC with signals for the GCH1 gene.
were either integrated into the chromosomes of HT1080 or the signals were undetectable by FISH analyses.
To examine whether the established HACs contained the genomic fragment of the GCH1 gene, four cell lines containing a HAC were further hybridized with probes for GCH1 exon 1 and exons 4-6 (Fig. 1) . The signals for both probes were detected on a HAC in the HT/ GCH2-10 cell line, which was generated by the cotransfection of CMV/ α 100 and GCH1-BAC, and on a HAC in the HT/GCH5-18 cell line which was generated by the co-transfection of SV/ α 50 and GCH1-BAC (Fig. 2) . The GCH1 signals detected on the HACs were stronger than those of the endogenous gene on the HT1080 chromosomes. As the minority of the cells (less than 5%) in both HT/GCH2-10 and HT/GCH5-18 were integrated with the transfected DNA into a chromosome of HT1080, the cell lines were single cell cloned to produce subclones containing only one copy of HAC per nuclei and the subsequent re-cloned cell lines were investigated further.
Centromere/kinetochore structure and mitotic stability of the HACs
To investigate the centromere/kinetochore structure on the HAC, the presence of essential centromere/kinetochore proteins, CENP-A and CENP-E (Palmer et al . 1991; Yen et al . 1991; Howman et al . 2000) was investigated on the metaphase chromosomes of HT/GCH2-10 and HT/GCH5-18 by indirect immunofluorescence. CENP-A and CENP-E signals were detected on HACs in doublets corresponding to the paired sister chromatids, and were similarly detected at the centromeres of all endogenous chromosomes (data not shown).
We examined the mitotic stability of the HACs in the cell lines HT/GCH2-10 and HT/GCH5-18 under the non-selective conditions. Maintenance of the HAC in each cell line was measured by FISH analysis on metaphase spreads, which were prepared after 10, 20 and 30 days of culturing. On each sampling day, 50 spreads from each cell line were examined and the percentage of cells that carried the HAC was determined. After 30 days without selection, 95% of metaphase cells in HT/ GCH5-18 and 80% of metaphase cells in HT/GCH2-10 retained the HAC and the number of HAC copies per cell was kept at one under non-selective conditions. Integration into host chromosomes was not observed in either cell line. The rate of chromosome loss per day was calculated from the percentages of cells retaining HAC after 30 days under non-selective conditions. The values were 0.2% and 0.5% for HT/GCH5-18 and HT/GCH2-10, respectively. These results indicated that an active centromere/kinetochore structure was formed on the HACs, and that the HACs were stably maintained through mitosis.
DNA structure of HACs
To determine whether the HACs in HT/GCH2-10 and HT/GCH5-18 were circular or linear, FISH was performed using a telomere sequence and BAC vector as probes. No telomere signal was detected on the HACs when the HACs were stained using a BAC vector probe (data not shown). In contrast, the ends of the chromosomes from the host cell, HT1080, were hybridized as clear speckles. As expected, BAC-derived HACs are likely to be circular in form.
The DNA organization of the HACs was analysed by restriction digestion of DNA isolated from HT/GCH2-10, HT/GCH5-18 and non-transfected HT1080 cells. The DNA samples were digested with Bam HI or Stu I, followed by conventional gel electrophoresis and hybridized with a probe consisting of either the upstream The HT/ GCH2-10 cell line, generated by co-transfection of CMV/α100 BAC and GCH1-BAC, and the cell line HT/GCH5-18 generated by co-transfection of SV/α50 BAC and GCH1-BAC, were hybridized with probes for GCH1 exon 1 (green) and BAC vector (red) (Left) or with probes for GCH1 exon 4 -6 (green) and GCH1 exon 1 (red) (Right). Arrowheads indicate HACs.
region of GCH1 (US) or GCH1 exon 6. The size of the Bam HI fragments detected by the US probe were 5.0 kb from the endogenous GCH1 gene and 3.5 kb from GCH1-BAC. The 5.0 and 3.5 kb fragments were detected with DNA from HT/GCH2-10 and HT/ GCH5-18 at almost the same signal intensity (Fig. 3A) . The size of the Stu I fragments detected by the exon 6 probe were 24.5 kb from the endogenous GCH1 gene and 14.4 kb from GCH1-BAC. The 24.5 and 14.4 kb fragments were detected with DNA from HT/GCH5-18 at almost the same signal intensity, while three fragments heterogeneous in size were detected in addition to the endogenous fragment with the DNA from HT/ GCH2-10 (Fig. 3B) . The results indicated that GCH1-containing HACs in HT/GCH5-18 were established by the assembly of about three copies of transfected GCH1-BAC DNA, since the karyo-type of HT1080 cells used in this study is 3n, while HT/GCH2-10 was accompanied by some rearrangements of the terminal region of GCH1 exon 6, but it may also contain three copies of Restriction analysis of GCH1 genes in HACs. Genomic DNAs from HT/GCH2-10, HT/GCH5-18 and nontransfected HT1080 were digested with BamHI (A) or StuI (B) and fractionated by conventional gel electrophoresis. The expected size of the BamHI and StuI fragments detected by the US probe (A) and the exon 6 probe (B), respectively, using the endogenous GCH1 locus and GCH1-HAC, are shown at the top. (C) Estimation of the copy number of GCH1-BAC and alphoid BAC in the HACs by dot hybridization. Left: The intensity value obtained with the GCH1 exon 6 probe. Input DNA of GCH1-BAC (0.4, 0.2, 0.1 ng) and genomic DNA (1.0, 0.5 µg) from HT1080, HT/GCH2-10 and HT/GCH5-18 were hybridized with the GCH1 exon 6 probe. The value obtained with 0.1 ng GCH1-BAC DNA was used as a standard. Right: The intensity value obtained with BAC vector probe. GCH1-BAC (0.5, 0.1, 0.05 ng) and genomic DNA (0.5, 0.25 µg) from HT1080, HT/GCH2-10 and HT/GCH5-18 were hybridized with the BAC vector probe. The signal intensity obtained with each probe was determined using a Fuji image-analyser BAS1000.
GCH1-BAC as judged by the density of the US band. The internal rearrangements of GCH1 genes were confirmed by the RT-PCR analyses of GCH1 transcripts in HT/GCH2-10, which revealed the synthesis of abnormal transcripts (data not shown).
The copy numbers of the GCH1-BAC and the alphoid-BAC in GCH2-10 and GCH5-18 HACs were determined by dot hybridization using GCH1 exon 6 and BAC vector, respectively, as probes. Relative copy numbers of each BAC in the HACs were estimated from the hybridization signal-intensity values, which were determined using each DNA probe and standardized using the values obtained with 0.1 ng GCH1-BAC DNA (Fig. 3C ). In the case where GCH1 exon 6 was used as the probe, the same hybridization intensity values to those obtained with 0.1 ng GCH1-BAC DNA were obtained with 0.5 µ g DNA from both HT/GCH2-10 and HT/GCH5-18, and with 1 µ g DNA from HT1080 (Fig. 3C, left) . Since the HT1080 karyo-type used in this study is 3n, three copies of GCH1 genes occur on its chromosomes, and given that HT/GCH2-10 and HT/GCH5-18 resulted in the same signal values with half the amount DNA as that from HT1080, they must contain six copies of GCH1 genes; three on the chromosomes and three on the HAC. The total copy number of BACs was estimated from the intensity values obtained with the BAC vector probe. The same hybridization intensity values to that obtained with 0.1 ng GCH1-BAC were obtained with 0.33 µ g DNA from HT/ GCH2-10 and HT/GCH5-18, while HT1080 showed no signal, as expected (Fig. 3C, Right) . Therefore, both HACs have roughly threefold more copies of the BAC vector than copies of the GCH1 gene. Thus, copy numbers of the total BAC vectors must be approximately nine per cell; three copies of GCH1 genes are in the form of GCH1-BAC and the remaining six copies of BACs must exist in the form of alphoid-BAC in both HACs.
Transfer of HAC-containing cell lines to mouse A9 cells
De novo HAC formation using cloned alphoid DNA has been successful in the human fibrocarcinoma cell line HT1080. To determine the natural expression of the GCH1 gene in the neural cell line, the HAC that has been established in the HT1080 cell line needs to be transferred into a neural cell line.
Fusion of the HAC-containing cell lines and mouse A9 cell line was performed using PEG which allows microcell mediated chromosome transfer (MMCT) (Fournier & Ruddle 1977) . BS-and Ouabain-resistant cell lines were analysed by FISH. Metaphase spreads were hybridized with a BAC vector probe and Alu repeat probe to identify the HACs and human chromosomes, respectively (Fig. 4A) . One of the fusion cell lines, F/GCH5-18, contained one or two copies of HAC together with 8 to 10 human chromosomes.
The HACs in the fusion cells were maintained stably during mitotic growth under non-selective conditions with a loss of ≈ 1% of the mitotic chromosomes per day (data not shown). The mitotic stability of human chromosomes in mouse cell lines was sometimes caused by the acquisition of minor satellite DNA from the mouse which was localized at the centromere of the mouse chromosomes and may serve as functional centromere sequences (Shen et al . 1997) . Therefore the presence of mouse minor satellite DNA on HAC was examined by FISH. Signals of minor satellite DNA were not detected on HAC, while strong signals were detected at the centromeres of mouse chromosomes (Fig. 4B) . The fusion cell lines were able to form microcells under colcemid treatment conditions (data not shown). Therefore, the HACs could easily be transferred to neural cell lines.
GCH1 expression from HAC
Naturally regulated gene expression was expected from the transgenes in the large genome segments carried by HACs. The GCH1-BAC used in the generation of HACs contained over 100 kb of genomic sequence from the 5′ upstream region of the GCH1 exon 1. Therefore, we have measured GTP cyclohydrolase I (GCH1) activities in HT1080 and the HAC-containing derivatives that were developed from it. It would have been expected from the previous report that the activity of GCH1 would have been hardly detectable in fibroblast cell lines, but up-regulated by induction of IFN-γ (Werner et al. 1990 ). GCH1 activity in HT1080, HT/ GCH2-10 and HT/GCH5-18 were analysed in the presence and absence of IFN-γ induction (Table 2) .
HT1080 without GCH1-HAC exhibited barely detectable levels of GCH1 activity in the absence of IFN-γ induction, while the activity was increased 15-fold following the addition of IFN-γ. In the HT/ GCH2-10 cell line in the absence of IFN-γ induction, the GCH1 level was three times the value of HT1080 without a HAC. After the IFN-γ induction, a nearly 30-fold up-regulation was observed. In contrast, GCH1 activity in HT/GCH5-18 was elevated 70-fold in the absence of IFN-γ, and the addition of IFN-γ further upregulated the activity fivefold. In both HT/GCH-HAC cell lines, the GCH1 activities were elevated but differ in degree, possibly reflecting the difference in chromatin structure and/or DNA rearrangements in HACs. They are still susceptible to IFN-γ induction, just like the response of the expression of the GCH1 gene from the authentic chromosome.
Discussion

The generation of HAC containing large DNA fragments
We obtained HACs containing large DNA fragments with the GCH1 gene (GCH1-HAC) by simple cotransfection methods using alphoid-BAC and GCH1-BAC at a DNA ratio of 1 : 1. The GCH1-HAC was maintained at one copy after 30 or more rounds of generation under non-selective conditions, in spite of being circular in form without telomeres, indicating that HAC replicates once in each cell cycle and is segregated precisely into daughter cells. Therefore, the circular HACs in this study did not cause a topological problem, which may result in the abnormal segregation of the circular chromosomes, since the catenated form arose from DNA replication. The HACs were cytologically megabases in size and approximately 10-fold larger than the transfected BAC DNA.
The DNA structure of the HAC was examined to understand the properties and mechanism of de novo generation of HAC. Restriction analysis of the whole area of the GCH1 gene was difficult because almost all rare-cutting enzyme sites in the BAC constructs were subjected to methylation and the cell lines contain the endogenous GCH1 locus. Therefore, we applied restriction analysis to the region corresponding to the junction of the BAC vector and the GCH1 locus. The result showed that GCH1-HACs in the two cell lines contained three copies of the GCH1-BAC and six copies of the alphoid-BAC as components (Fig. 3) . Although the exact mechanism of the formation of the HAC remains unknown, GCH1-HAC was composed of a multimer of the input DNA, which was similar to the HAC generated by alphoid-YAC or alphoid-BAC alone (data not shown), as an input element. The fact that the formation of HAC was accompanied by an assembly of the distinct BACs indicated that the multimerization of BAC molecules might be mediated by a nonspecific recombination of input BAC in addition to the amplification of BAC DNA itself.
Generation of the HAC containing large human genomic DNA was previously reported using a 140 kb or 162 kb HPRT locus (Grimes et al. 2001; Mejia et al. 2001) . They obtained the HAC containing HPRT gene in the HPRT-deficient HT1080 cell lines in HAT medium depending on complementation. The feasibility of such an approach for genes with tissue and stage specific expression (i.e. not house-keeping genes) will be low in HT1080 cells. In this study, we found that as little as 50 kb of α21-I alphoid DNA in BAC was able to generate HACs (centromere/kinetochore) and that the BACs containing a large transgene without selection markers could be incorporated efficiently into the HAC, since 50% of the HACs included the transgene. Thus, HACs containing any large genomic region of interest could be generated using alphoid-BAC containing 50 kb of alphoid DNA and a readily available BAC library without any modification. The completeness of the incorporated transgenes may be checked after HAC generation. Selection of transformants with the CMV promoterdriven Bsd gene increases the number of BS-resistant cells, but the FISH signals for HACs or integrated loci on the host chromosomes were not found in the majority of transformants (Table 1) . Southern hybridization analyses using alphoid and BAC vector sequences as probes indicated that these cell lines only have Bsd genes integrated in the chromosomes. Thus, the selection marker, driven by a high expression promoter, was not suitable for the screening of HAC-containing cell lines.
Centromere/kinetochore structure of HAC Gene expression was affected by chromosome structure. The insertion of a transgene into a chromosome often results in stably inherited gene silencing in a clonal subpopulation of the cells, a phenomenon which is commonly known as position effect variegation (PEV) (Karpen 1994) . Recent molecular analysis showed that the methylation of histone H3 on lysine 9 contributes to the targeting of HP1 to the chromatin and results in heterochromatinization and the silencing of gene expression (Platero et al. 1995; Bannister et al. 2001; Lachner et al. 2001) . Gene silencing at or near the centromere/kinetochore in yeast and fly was also reported (Karpen & Allshire 1997) , and was expected to occur in mammalian cells. We have recently demonstrated that in the alphoid array of a HAC, once the centomere/kinetochore structure has formed, the expression of the short marker genes inserted into the HACs were repressed strongly, even if they were driven by strong promoters (T. Abe, K. Yamamoto & T. Okazaki, submitted). Thus, to get expression of transgenes in HACs, we will need to solve the topological problem of the genes in relation to the centromere/kinetochore structure.
The GCH1 gene expression from HAC might be correlated with the chromatin structure at or near the GCH1 locus. We addressed whether the centromere/ kinetochore structure was formed on only the alphoid array or whether it spread into the GCH1 locus. Since CENP-A is an essential protein for a functional centromere/kinetochore and constitutes the histone component for centromere specific nucleosomes (Palmer et al. 1991; Howman et al. 2000) , we analysed the chromatin structure on HAC by ChIP using an anti-CENP-A antibody (Ando et al. 2002) . In such analyses using HeLa and HT1080 cells, the alphoid array was enriched to 60 -80% in total immunoprecipitated DNA. The alphoid array in the GCH1-HAC was also enriched by anti-CENP-A antibody, while the GCH1 region was not. In contrast, the BAC vector sequence about 3 kb away from the alphoid sequence was also immunoprecipitated, indicating that the centromere/kinetochore structure was formed on the alphoid array and spread to the flanking nonalphoid region (data not shown). Invasion of the GCH1 locus in the HAC by centromere/kinetochore structure was prevented by an as yet unknown protection mechanism that probably resides in the upstream regulatory sequence.
Authentic gene expression from HAC
GCH1 encodes the first and rate-limiting enzyme for the biosynthetic pathway of tetrahydrobiopterin (Nichol et al. 1985) , the co-factor of aromatic amino acid hydroxylase (PAH, TH, TPH), as well as nitric oxide synthase (NOS), and is present in higher organisms (Kaufman 1993) . The GCH1 gene is a causative gene for dopamine deficiency in dopa responsive dystonia (DRD/Segawa's disease) (Ichinose et al. 1994) . Deficiency of GCH1 in conjunction with a mutation in the TH gene results in severe early onset dystonia/parkinsonism (Ichinose et al. 1999) .
Although only limited analyses have been performed on the upstream regulatory sequence of the human and mouse GCH1 gene, it has been reported that the CCAAT and TATA boxes are conserved (Ichinose et al. 1995; Hubbard et al. 2002) . It was established that GCH1 gene expression could be induced by IFN-γ in various rodent and human cells (Werner et al. 1990 ). However, the exact mechanism involved in IFN-γ signal transduction is as yet unknown.
Some gene expression, such as that for human β-globin, is regulated by the locus control regions (LCRs) responsible for initiating and maintaining a stable tissuespecific open chromatin structure (Festentein et al. 1996; Milot et al. 1996) . The GCH1-HACs used in this study carry a 180 kb genomic fragment containing the GCH1 gene, and may therefore contain the regulatory sequences required for tissue specific expression and for prevention of the silencing effect of the flanking centromere. The expression of the GCH1 gene from HAC was measured by GTP cyclohydrolase I activity in the presence and absence of IFN-γ (Table 2) . Activity in the HAC-containing cell line, HT/GCH2-10, was slightly higher than the activity obtained with HT1080 in the absence of IFN-γ. Addition of IFN-γ increased the GCH1 activity approximately 30-fold. In another cell line, HT/GCH5-18, which also carries twice the number of GCH1 genes as HT1080, showed a 70-fold higher enzyme activity than TH1080 in the absence of IFN-γ and the activity was further increased fivefold by IFN-γ induction. The small difference in values between HT/GCH2-10 and HT1080 may correspond to the small copy numbers of the intact GCH1 genes, since it seems that some copies of GCH1 genes on GCH2-10 HAC have the structural abnormality described in the Results section. It will require further study to determine the exact reason why the basal level of the GCH1 activity in HT/GCH5-18 is higher. One possibility, however, might be the elevated copy numbers of GCH1 loci on the HAC, since there is a greater likelihood that chromatin assembly on some of the copies might be imprecise. These results also indicated that, although the gene expression of GCH1 may be affected by the difference of chromatin structure assembled on the GCH1 locus in the HAC, the genes still responded to IFN-γ. Considering that the value of the GCH1 activity of IFN-γ induced human macrophage was 240 pmol/ h/mg (Werner et al. 1990 ) and that of LPS induced murine neuroblastoma cell line N1E was more than 300 pmol/h/mg (Ota et al. 1996) , the final levels of GCH1 activity after IFN-γ induction in the cell lines were still repressed and kept to a similar order of magnitude. This might indicate the presence of complex cellular regulation systems to keep GCH1 activity in the proper range. The GCH1-HAC should prove to be a suitable system for understanding the complex regulatory mechanisms of GCH1 expression in vivo. This is the first report in which gene expression on the HAC was quantitatively analysed and the results positively supported the HAC system.
Utility of HAC as a gene transfer vector for mammalian cells
The adeno-associated virus (AAV) vector has often been used for gene therapy in a helper virus-dependent manner for productive infection. The AAV vector has a limited cloning capacity that usually carries cDNA without the original regulatory sequence for gene expression (Dong et al. 1996) . GCH1 is necessary for efficient dopamine production together with tyrosine hydroxylase (TH) and aromatic-l-amino acid decarboxylase (AADC). The expression of these three enzymes from the AAV vector in the striatum resulted in relatively long-term behavioural recovery in a primate model of Parkinson's disease (Muramatsu et al. 2002) .
Recently, an Epstein-Barr virus (EBV)-based episomal vector was reported that was capable of transferring an HPRT gene (115 kb) to some mammalian cell lines, in which the expression was not silenced (Wade-Martins et al. 2000) . However, EBV-based vectors are lost more rapidly than HAC in the absence of selection and their replication is reliant on the presence of the viral transactivator, EBNA1. Safety in clinical gene therapy with EBV vectors requires further investigation. HACs may overcome the above problems as gene transfer vectors and have further advantages in term of safety. HACs carrying a long genomic locus in this study were maintained extrachromosomally, and expressed regulated levels of genes for long periods. Therefore, the HAC containing TH, AADC and GCH1 may offer a potential therapeutic strategy for Parkinson's disease.
However, the low efficiency of the de novo generation of HACs from BACs, the requirement of the limited cell line for generation of HACs and the large size of HACs presents a difficulty in the delivery of HACs to cells or tissues at required sites. To utilize the HAC as a gene transfer vector, the HAC that has been established in HT1080 needs to be transferred into suitable cell lines. The HAC could be transferred by MMCT using mouse A9 cells, which enable the formation of microcells (Fournier & Ruddle 1977) . We have established mouse A9 cell lines, which maintained HACs stably in mitotic growth under non-selective conditions without detectable structural changes in the HAC. The HACs would be easily transferrable from A9 to other cell lines.
In this study we have demonstrated the generation of a HAC containing the GCH1 gene, together with its original regulatory region, from a GCH1-BAC by cotransfection with the alphoid-BAC. The GCH1-HACs expressed GCH1 genes in a regulated manner and thus proved to be a good system for study of the regulatory mechanism of the GCH1 gene in vivo. Further study on the GCH1-HACs will reveal the minimum number of alphoid arrays used to assemble centromere/kinetochore, the structure of the upstream region required for the regulated expression of the GCH1 gene and the sites of action of transcription factors on the regulatory region. The results we have obtained also indicated that the GCH1-HAC may also serve as a gene delivery tool in animal models or future therapeutic trials.
Experimental procedures
Construction of alphoid-BAC
pBAC-TAN was created by the insertion of a MluI-SfiI-SacII linker into the XhoI site of pBeloBAC11. pBAC-CMV and pBAC-SV were created by the insertion of a 1.3 kb NotI-HindIII fragment from pCMV/Bsd (Invitrogen) or a 2.6 kb PvuII-EcoRI fragment from pSV2bsr (Kakenseiyaku), both containing a Blasticidin S resistance gene, into the NotI-HindIII sites of pBAC-TAN. The 25 kb α 21-I alphoid fragment (α25) was isolated from the cosmid clone, Q25F12, obtained from the LL21NC02 library (Lawrence Livermore Laboratory) by SfiI digestion and cloned into the SfiI site of pBAC-TAN. The resulting alphoid-BACs, which contain either 50 kb or 100 kb of tandem alphoid insert, were digested with MluI and SacII, and the alphoid fragments were inserted into the MluI-SacII sites of pBAC-CMV or pBAC-SV, respectively.
Transfection
BAC-DNAs were purified by CsCl banding using a gradient. For the generation of HAC, 0.5 µg of alphoid-BACs and 1.0 µg of GCH1-BAC (186L09, Genomesystems) were co-transfected into HT1080 cells (5 × 10 5 ) using lipofectamine (Gibco BRL) according to the manufacturer's instructions. The cells were selected with 4 µg/mL Blasticidin S (BS, Kakenseiyaku) and colonies were picked after 10 days.
FISH
Metaphase chromosome spreads were prepared on glass slides after methanol/acetate (3 : 1) fixation and FISH was carried out according to conventional procedures. For the detection of HAC, biotin-labelled α 21-I alphoid DNA (11-4) (Ikeno et al. 1994 ) and digoxigenin-labelled pBeloBAC11 were used as probes. GCH1 genes were detected with a biotin-labelled 13 kb fragment containing exon 1 and with a digoxigenin-labelled 8 kb fragment containing GCH1 exons 4, 5 and 6. In dual FISH, biotin-labelled DNA was visualized with FITC conjugated avidin (Vector), and digoxigenin-labelled DNA was visualized with TRITC conjugated anti-digoxigenin (Boehringer Mannheim). Photographs were taken using a CCD camera (Princeton instruments) mounted on a Zeiss microscope. Images were processed using IPLab and Adobe Photoshop 6.0.
Indirect immunofluorescence
Swollen and 1% paraformaldehyde fixed cells were incubated with anti-CENP-A (Ando et al. 2002) or anti-CENP-E (Santa Cruz) antibodies. Antibody localization was visualized with FITCconjugated anti-mouse IgG. For the subsequent FISH analysis, the cells were fixed again with 1% paraformaldehyde and then with methanol/acetate (3 : 1).
Restriction-enzyme digestion and hybridization
Genomic DNA (5 µg) from cell lines were digested for 4 h and fractionated by conventional gel electrophoresis. The DNA in the gel was transferred to a nylon membrane and hybridized with 32 P labelled DNA probe prepared from GCH1 exon 6 (2.1 kb) and the upstream region of GCH1 (1.4 kb, position 595-1959 in GCH1-BAC).
Mitotic stability
The mitotic stability of GCH1-HAC was measured by culturing the cells for approximately 30 days under non-selective growth conditions. With each of the cell lines after 10, 20 and 30 days culture in the absence of BS selection, spreads of metaphase chromosomes were prepared, and the presence of HACs was analysed by FISH. The percentage of metaphase cells with HAC, from a total of 50 spreads, was measured. The rate of HAC loss (R) was calculated by the following formula: N n = N 0 × (1 − R) n , where N 0 is the number of the metaphase spreads containing a HAC under selective conditions, and N n is the number of metaphase spreads containing a HAC after n days of culture under non-selective conditions.
Cell fusion
Cell lines containing a HAC (5 × 10 5 ) and mouse A9 cells (5 × 10 5 ) were co-cultivated and fused in PEG/DMSO solution (Sigma). BS-and Ouabain-resistant cells were selected with 2.5 µg/mL BS and 3 µm Ouabain.
